Teligent Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,700.00
5,251.00
6,668.00
11,985.00
15,191.00
36,256
Depreciation, Depletion & Amortization
535.00
635.00
1,174.00
3,779.00
4,641.00
5,675
Other Funds
-
94.00
19.00
36.00
-
23,938
Funds from Operations
1,128.00
5,085.00
5,276.00
5,852.00
1,376.00
6,570
Changes in Working Capital
1,746.00
8,976.00
10,237.00
4,754.00
1,776.00
6,705
Net Operating Cash Flow
618.00
3,891.00
15,513.00
1,098.00
400.00
13,275
Capital Expenditures
2,113.00
3,792.00
53,068.00
21,972.00
40,429.00
Net Investing Cash Flow
2,113.00
3,792.00
53,068.00
21,972.00
40,429.00
Issuance/Reduction of Debt, Net
1,983.00
138,676.00
3,292.00
70.00
-
Net Financing Cash Flow
2,296.00
164,465.00
3,111.00
10.00
269.00
Net Change in Cash
435.00
156,782.00
71,692.00
21,185.00
39,314.00
Free Cash Flow
905.00
4,725.00
68,581.00
20,874.00
40,029.00
Change in Capital Stock
313.00
25,695.00
162.00
96.00
269.00
Exchange Rate Effect
-
-
-
301.00
446.00

About Teligent

View Profile
Address
105 Lincoln Avenue
Buena New Jersey 08310
United States
Employees -
Website http://www.teligent.com
Updated 07/08/2019
Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E.